SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-017407
Filing Date
2024-02-20
Accepted
2024-02-20 19:41:57
Documents
1
Period of Report
2024-02-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12638
  Complete submission text file 0000950170-24-017407.txt   14079
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E. SUITE 208 SEATTLE WA 98102
Business Address
Shiver John W. (Reporting) CIK: 0001900372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 24655894